Cannabinoid receptor type 2, but not type 1, is up-regulated in peripheral blood mononuclear cells of children affected by autistic disorders

Journal of Autism and Developmental Disorders

Volumn 43, Issue 11, 2013, Pages 2686-2695

  Siniscalco, Dario ^a,b   Sapone, Anna ^a,c   Giordano, Catia ^a   Cirillo, Alessandra ^a   De Magistris, Laura ^a   Rossi, Francesco ^a   Fasano, Alessio ^c   Bradstreet, James Jeffrey ^d   Maione, Sabatino ^a   Antonucci, Nicola ^e  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b Centre for Autism La Forza del Silenzio   (Italy)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d International Child Development Resource Center   (United States)

^e Biomedical Centre for Autism Research and Treatment   (Italy)

Author keywords

Autistic disorders; Cannabinoid system; Gene expression; PBMCs

Indexed keywords

CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; ENDOCANNABINOID; FATTY ACID AMIDASE; G PROTEIN COUPLED RECEPTOR; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MESSENGER RNA; PHOSPHATIDYLETHANOLAMINE; PHOSPHOLIPASE D;

ARTICLE; AUTISM; CHILD; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HYDROLYSIS; MALE; MOLECULAR PATHOLOGY; PERIPHERAL BLOOD MONONUCLEAR CELL; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEPTOR UPREGULATION; SCHOOL CHILD; UPREGULATION;

CHILD; CHILD DEVELOPMENT DISORDERS, PERVASIVE; CHILD, PRESCHOOL; FEMALE; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; RECEPTOR, CANNABINOID, CB1; RECEPTOR, CANNABINOID, CB2; UP-REGULATION;

EID: 84886950001     PISSN: 01623257     EISSN: 15733432     Source Type: Journal    
DOI: 10.1007/s10803-013-1824-9     Document Type: Article

References (65)

1. Agudelo, M.; Newton, C.; Widen, R.; Sherwood, T.; Nong, L.; Friedman, H.; et al. (2008). Cannabinoid receptor 2 (CB2) mediates immunoglobulin class switching from IgM to IgE in cultures of murine-purified B lymphocytes. Journal of Neuroimmune Pharmacology, 3(1), 35-42.
2. Alessio, N.; Squillaro, T.; Cipollaro, M.; Bagella, L.; Giordano, A.; Galderisi, U. (2010). The BRG1 ATPase of chromatin remodeling complexes is involved in modulation of mesenchymal stem cell senescence through RB-P53 pathways. Oncogene, 29(40), 5452-5463.
3. Algeciras-Schimnich, A.; Barnhart, B. C.; Peter, M. E. (2002). Apoptosis independent functions of killer caspases. Current Opinion in Cell Biology, 14, 721-726.
4. American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (4th ed.). Text Revision. Washington, DC: American Psychiatric Press.
5. Ardura, J. A.; Friedman, P. A. (2011). Regulation of g protein-coupled receptor function by na +/h + exchange regulatory factors. Pharmacological Reviews, 63(4), 882-900.
6. Ashwood, P.; Krakowiak, P.; Hertz-Picciotto, I.; Hansen, R.; Pessah, I.; Van de Water, J. (2011). Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome. Brain, Behavior, and Immunity, 25(1), 40-45.
7. Ashwood, P.; Wills, S.; Van de Water, J. (2006). The immune response in autism: A new frontier for autism research. Journal of Leukocyte Biology, 80(1), 1-15.
8. Barna, I.; Zelena, D. (2012). The biochemical complexity of the endocannabinoid system with some remarks on stress and related disorders: A minireview. Endocrine Regulations, 46(2), 107-124.
9. Basu, S.; Dittel, B. N. (2011). Unraveling the complexities of cannabinoid receptor 2 (CB2) immune regulation in health and disease. Immunologic Research, 51(1), 26-38.
10. Bradford, M. M. (1976). A rapid and sensitive method for the quantization of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry, 72, 248-254.
11. Cencioni, M. T.; Chiurchiù, V.; Catanzaro, G.; Borsellino, G.; Bernardi, G.; Battistini, L.; et al. (2010). Anandamide suppresses proliferation and cytokine release from primary human T-lymphocytes mainly via CB2 receptors. PLoS ONE, 5(1), e8688.
12. de Magistris, L.; Familiari, V.; Pascotto, A.; Sapone, A.; Frolli, A.; Iardino, P.; et al. (2010). Alterations of the intestinal barrier in patients with autism spectrum disorders and in their first-degree relatives. Journal of Pediatric Gastroenterology and Nutrition, 51(4), 418-424.
13. Di Filippo, C.; Rossi, F.; Rossi, S.; D'Amico, M. (2004). Cannabinoid CB2 receptor activation reduces mouse myocardial ischemia-reperfusion injury: Involvement of cytokine/chemokines and PMN. Journal of Leukocyte Biology, 75(3), 453-459.
14. Di Marzo, V.; Petrosino, S. (2007). Endocannabinoids and the regulation of their levels in health and disease. Current Opinion in Lipidology, 18(2), 129-140.
15. Dong, R.; Dong, K.; Wang, X.; Chen, G.; Shen, C.; Zheng, S. (2012). Interleukin-33 overexpression is associated with gamma-glutamyl transferase in biliary atresia. Cytokine, S1043-4666(12), 00771-00775.
16. Enstrom, A. M.; Onore, C. E.; Van de Water, J. A.; Ashwood, P. (2010). Differential monocyte responses to TLR ligands in children with autism spectrum disorders. Brain, Behavior, and Immunity, 24(1), 64-71.
17. Galiègue, S.; Mary, S.; Marchand, J.; Dussossoy, D.; Carrière, D.; Carayon, P.; et al. (1995). Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. European Journal of Biochemistry, 232(1), 54-61.
18. Garcia-Gutierrez, M. S.; Manzanares, J. (2011). Overexpression of CB2 cannabinoid receptors decreased vulnerability to anxiety and impaired anxiolytic action of alprazolam in mice. Journal of Psychopharmacology, 25(1), 111-120.
19. Giordano, C.; Siniscalco, D.; Melisi, D.; Luongo, L.; Curcio, A.; Soukupova, M.; et al. (2011). The galactosylation of N(ω)-nitro-l-arginine enhances its anti-nocifensive or anti-allodynic effects by targeting glia in healthy and neuropathic mice. European Journal of Pharmacology, 656(1-3), 52-62.
20. Guo, Y.; Xiao, P.; Lei, S.; Deng, F.; Xiao, G. G.; Liu, Y.; et al. (2008). How is mRNA expression predictive for protein expression? A correlation study on human circulating monocytes. Acta Biochimica et Biophysica Sinica (Shanghai), 40(5), 426-436.
21. Gupta, S.; Samra, D.; Agrawal, S. (2010). Adaptive and innate immune responses in autism: rationale for therapeutic use of intravenous immunoglobulin. Journal of Clinical Immunology, 30, S90-S96.
22. Gygi, S. P.; Rochon, Y.; Franza, B. R.; Aebersold, R. (1999). Correlation between protein and mRNA abundance in yeast. Molecular and Cellular Biology, 19(3), 1720-1730.
23. Hegde, V. L.; Nagarkatti, M.; Nagarkatti, P. S. (2010). Cannabinoid receptor activation leads to massive mobilization of myeloid-derived suppressor cells with potent immunosuppressive properties. European Journal of Immunology, 40(12), 3358-33571.
24. Högestätt, E. D.; Jönsson, B. A.; Ermund, A.; Andersson, D. A.; Björk, H.; Alexander, J. P.; et al. (2005). Conversion of acetaminophen to the bioactive N-acylphenolamine AM404 via fatty acid amide hydrolase-dependent arachidonic acid conjugation in the nervous system. Journal of Biological Chemistry, 280(36), 31405-31412.
25. Ishiguro, H.; Horiuchi, Y.; Ishikawa, M.; Koga, M.; Imai, K.; Suzuki, Y.; et al. (2010). Brain cannabinoid CB2 receptor in schizophrenia. Biological Psychiatry, 67(10), 974-982.
26. Jean-Gilles, L.; Gran, B.; Constantinescu, C. S. (2010). Interaction between cytokines, cannabinoids and the nervous system. Immunobiology, 215(8), 606-610.
27. Kenny, P. J. (2011). Macrophage cannabinoid receptor goes up in smoke. Nature Neuroscience, 14, 1100-1102.
28. Klein, T. W.; Cabral, G. A. (2006). Cannabinoid-induced immune suppression and modulation of antigen-presenting cells. Journal of Neuroimmune Pharmacology, 1(1), 50-64.
29. Klein, T. W.; Newton, C.; Larsen, K.; Lu, L.; Perkins, I.; Nong, L.; et al. (2003). The cannabinoid system and immune modulation. Journal of Leukocyte Biology, 74(4), 486-496.
30. Lamkanfi, M.; Declercq, W.; Kalai, M.; Saelens, X.; Vandenabeele, P. (2002). Alice in caspase land. A phylogenetic analysis of caspases from worm to man. Cell Death and Differentiation, 9, 358-361.
31. Levy, S. E.; Mandell, D. S.; Schultz, R. T. (2009). Autism. Lancet, 374(9701), 1627-1638.
32. Li, X.; Chauhan, A.; Sheikh, A. M.; Patil, S.; Chauhan, V.; Li, X. M.; et al. (2009). Elevated immune response in the brain of autistic patients. Journal of Neuroimmunology, 207(1-2), 111-116.
33. Li, C.; Jones, P. M.; Persaud, S. J. (2011). Role of the endocannabinoid system in food intake, energy homeostasis and regulation of the endocrine pancreas. Pharmacology & Therapeutics, 129(3), 307-320.
34. Lord, C.; Risi, S.; Lambrecht, L.; Cook, E. H.; Jr, Leventhal, B. L.; DiLavore, P. C.; et al. (2000). The autism diagnostic observation schedule-generic: A standard measure of social and communication deficits associated with the spectrum of autism. Journal of Autism and Developmental Disorders, 30(3), 205-223.
35. Lord, C.; Rutter, M.; Le Couteur, A. (1994). Autism diagnostic interview-revised: A revised version of a diagnostic interview for caregivers of individuals with possible Pervasive Developmental Disorders. Journal of Autism and Developmental Disorders, 24(5), 659-685.
36. Maccarrone, M.; De Petrocellis, L.; Bari, M.; Fezza, F.; Salvati, S.; Di Marzo, V.; et al. (2001). Lipopolysaccharide downregulates fatty acid amide hydrolase expression and increases anandamide levels in human peripheral lymphocytes. Archives of Biochemistry and Biophysics, 393(2), 321-328.
37. Maier, T.; Güell, M.; Serrano, L. (2009). Correlation of mRNA and protein in complex biological samples. FEBS Letters, 583(24), 3966-3973.
38. Meyer, S.; Temme, C.; Wahle, E. (2004). Messenger RNA turnover in eukaryotes: Pathways and enzymes. Critical Reviews in Biochemistry and Molecular Biology, 39(4), 197-216.
39. Minocci, D.; Massei, J.; Martino, A.; Milianti, M.; Piz, L.; Di Bello, D.; et al. (2011). Genetic association between bipolar disorder and 524A > C (Leu133Ile) polymorphism of CNR2 gene, encoding for CB2 cannabinoid receptor. Journal of Affective Disorders, 134(1-3), 427-430.
40. Molloy, C. A.; Morrow, A. L.; Meinzen-Derr, J.; Schleifer, K.; Dienger, K.; Manning-Courtney, P.; et al. (2006). Elevated cytokine levels in children with autism spectrum disorder. Journal of Neuroimmunology, 172(1-2), 198-205.
41. Mouslech, Z.; Valla, V. (2009). Endocannabinoid system: An overview of its potential in current medical practice. Neuro Endocrinology Letters, 30(2), 153-179.
42. Nagarkatti, P.; Pandey, R.; Rieder, S. A.; Hegde, V. L.; Nagarkatti, M. (2009). Cannabinoids as novel anti-inflammatory drugs. Future Medicinal Chemistry, 1(7), 1333-1349.
43. Nong, L.; Newton, C.; Cheng, Q.; Friedman, H.; Roth, M. D.; Klein, T. W. (2002). Altered cannabinoid receptor mRNA expression in peripheral blood mononuclear cells from marijuana smokers. Journal of Neuroimmunology, 127(1-2), 169-176.
44. Onore, C.; Enstrom, A.; Krakowiak, P.; Hertz-Picciotto, I.; Hansen, R.; Van de Water, J.; et al. (2009). Decreased cellular IL-23 but not IL-17 production in children with autism spectrum disorders. Journal of Neuroimmunology, 216(1-2), 126-129.
45. Pacher, P.; Mechoulam, R. (2011). Is lipid signaling through cannabinoid 2 receptors part of a protective system? Progress in Lipid Research, 50(2), 193-211.
46. Pascal, L. E.; True, L. D.; Campbell, D. S.; Deutsch, E. W.; Risk, M.; Coleman, I. M.; et al. (2008). Correlation of mRNA and protein levels: Cell type-specific gene expression of cluster designation antigens in the prostate. BMC Genomics, 9, 246.
47. Peralta, L.; Agirregoitia, E.; Mendoza, R.; Expósito, A.; Casis, L.; Matorras, R.; et al. (2011). Expression and localization of cannabinoid receptors in human immature oocytes and unfertilized metaphase-II oocytes. Reprod Biomed Online, 23(3), 372-379.
48. Pertwee, R. G.; Howlett, A. C.; Abood, M. E.; Alexander, S. P.; Di Marzo, V.; Elphick, M. R.; et al. (2010). Cannabinoid receptors and their ligands: Beyond CB1 and CB2. Pharmacological Reviews, 62(4), 588-631.
49. Rajagopalan, L. E.; Malter, J. S. (1997). Regulation of eukaryotic messenger RNA turnover. Progress in Nucleic Acid Research and Molecular Biology, 56, 257-286.
50. Robinson, S. A.; Loiacono, R. E.; Christopoulos, A.; Sexton, P. M.; Malone, D. T. (2010). The effect of social isolation on rat brain expression of genes associated with endocannabinoid signaling. Brain Research, 1343, 153-167.
51. Romero-Calvo, I.; Ocón, B.; Martínez-Moya, P.; Suárez, M. D.; Zarzuelo, A.; Martínez-Augustin, O.; et al. (2010). Reversible Ponceau staining as a loading control alternative to actin in Western blots. Analytical Biochemistry, 401(2), 318-320.
52. Ross, J. (1996). Control of messenger RNA stability in higher eukaryotes. Trends in Genetics, 12(5), 171-175.
53. Schneider, M.; Koch, M. (2005). Deficient social and play behavior in juvenile and adult rats after neonatal cortical lesion: Effects of chronic pubertal cannabinoid treatment. Neuropsychopharmacology, 30(5), 944-957.
54. Schopler, E.; Reichler, R. J.; Renner, B. R. (1993). The childhood autism rating scale (CARS). Los Angeles, CA: Western Psychological Services.
55. Schultz, S. T. (2010). Can autism be triggered by acetaminophen activation of the endocannabinoid system? Acta Neurobiologiae Experimentalis, 70(2), 227-231.
56. Siniscalco, D.; Sapone, A.; Giordano, C.; Cirillo, A.; de Novellis, V.; de Magistris, L.; et al. (2012). The expression of caspases is enhanced in peripheral blood mononuclear cells of autism spectrum disorder patients. Journal of Autism and Developmental Disorders, 42(7), 1403-1410.
57. Soukupová, M.; Palazzo, E.; De Chiaro, M.; Gatta, L.; Migliozzi, A. L.; Guida, F.; et al. (2010). Effects of URB597, an inhibitor of fatty acid amide hydrolase (FAAH), on analgesic activity of paracetamol. Neuro Endocrinology Letters, 31(4), 507-511.
58. Stamova, B. S.; Apperson, M.; Walker, W. L.; Tian, Y.; Xu, H.; Adamczy, P.; et al. (2009). Identification and validation of suitable endogenous reference genes for gene expression studies in human peripheral blood. BMC Medical Genomics, 2, 49.
59. Suzuki, K.; Matsuzaki, H.; Iwata, K.; Kameno, Y.; Shimmura, C.; Kawai, S.; et al. (2011). Plasma cytokine profiles in subjects with high-functioning autism spectrum disorders. PLoS ONE, 6(5), e20470.
60. Tanikawa, T.; Kurohane, K.; Imai, Y. (2011). Regulatory effect of cannabinoid receptor agonist on chemokine-induced lymphocyte chemotaxis. Biological and Pharmaceutical Bulletin, 34(7), 1090-1093.
61. Tománková, H.; Myslivecek, J. (2012). Regulation of receptors coupled to G proteins (GPCRs). Ceskoslovenska Fysiologie, 61(1), 15-23.
62. Wilusz, C. J.; Wormington, M.; Peltz, S. W. (2001). The cap-to-tail guide to mRNA turnover. Nature Reviews Molecular Cell Biology, 2(4), 237-246.
63. Yang, M.; Liu, Y.; Lu, S.; Wang, Z.; Wang, R.; Zi, Y.; et al. (2013). Analysis of the expression levels of survivin and VEGF in patients with acute lymphoblastic leukemia. Experimental and Therapeutic Medicine, 5(1), 305-307.
64. Zanichelli, F.; Capasso, S.; Cipollaro, M.; Pagnotta, E.; Cartenì, M.; Casale, F.; et al. (2012). Dose-dependent effects of R-sulforaphane isothiocyanate on the biology of human mesenchymal stem cells, at dietary amounts, it promotes cell proliferation and reduces senescence and apoptosis, while at anti-cancer drug doses, it has a cytotoxic effect. Age (Dordr), 34(2), 281-293.
65. Zhu, C.; Solorzano, C.; Sahar, S.; Realini, N.; Fung, E.; Sassone-Corsi, P.; et al. (2011). Proinflammatory stimuli control N- acylphosphatidylethanolamine-specific phospholipase D expression in macrophages. Molecular Pharmacology, 79(4), 786-792.